Decision of the EEA Joint Committee No 312/2022 of 9 December 2022 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1254]
Date: 2022-12-09
Institutions: EEA Joint Committee
Subjects: European Economic Area, market approval, plant health control, plant health product, revision of an agreement




L_2023164EN.01003901.xml










29.6.2023   


EN


Official Journal of the European Union


L 164/39








            DECISION OF THE EEA JOINT COMMITTEE No 312/2022
of 9 December 2022
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1254]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2021/2049 of 24 November 2021 renewing the approval of the active substance cypermethrin as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2021/2081 of 26 November 2021 concerning the non-renewal of approval of the active substance indoxacarb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2022/4 of 4 January 2022 approving the active substance Purpureocillium lilacinum strain PL11 as a low-risk substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) 2022/19 of 7 January 2022 renewing the approval of the active substance Purpureocillium lilacinum strain 251 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 renewing the approval of the active substance flumioxazin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annexes to Commission Implementing Regulation (EU) No 540/2011 and to Implementing Regulation (EU) 2015/408 (6) is to be incorporated into the EEA Agreement.












(7)


Commission Implementing Regulation (EU) 2022/159 of 4 February 2022 approving the low-risk active substance Bacillus amyloliquefaciens strain IT-45 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (7) is to be incorporated into the EEA Agreement.












(8)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘–



32021 R 2049: Commission Implementing Regulation (EU) 2021/2049 of 24 November 2021 (OJ L 420, 25.11.2021, p. 6),










–



32021 R 2068: Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 (OJ L 421, 26.11.2021, p. 25),










–



32021 R 2081: Commission Implementing Regulation (EU) 2021/2081 of 26 November 2021 (OJ L 426, 29.11.2021, p. 28),










–



32022 R 0004: Commission Implementing Regulation (EU) 2022/4 of 4 January 2022 (OJ L 1, 5.1.2022, p. 5),










–



32022 R 0019: Commission Implementing Regulation (EU) 2022/19 of 7 January 2022 (OJ L 5, 10.1.2022, p. 9),










–



32022 R 0043: Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 (OJ L 9, 14.1.2022, p. 7),










–



32022 R 0159: Commission Implementing Regulation (EU) 2022/159 of 4 February 2022 (OJ L 26, 7.2.2022, p. 7).’














2.


The following indent is added in point 13zzzzt (Commission Implementing Regulation (EU) 2015/408):






‘-



32022 R 0043: Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 (OJ L 9, 14.1.2022, p. 7).’














3.


The following points are inserted after point 13zzzzzzzzzzzzf (Commission Implementing Regulation (EU) 2021/1451):






‘13zzzzzzzzzzzzg.



32021 R 2049: Commission Implementing Regulation (EU) 2021/2049 of 24 November 2021 renewing the approval of the active substance cypermethrin as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 420, 25.11.2021, p. 6).










13zzzzzzzzzzzzh.



32021 R 2081: Commission Implementing Regulation (EU) 2021/2081 of 26 November 2021 concerning the non-renewal of approval of the active substance indoxacarb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 426, 29.11.2021, p. 28).










13zzzzzzzzzzzzi.



32022 R 0004: Commission Implementing Regulation (EU) 2022/4 of 4 January 2022 approving the active substance Purpureocillium lilacinum strain PL11 as a low-risk substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 1, 5.1.2022, p. 5).










13zzzzzzzzzzzzj.



32022 R 0019: Commission Implementing Regulation (EU) 2022/19 of 7 January 2022 renewing the approval of the active substance Purpureocillium lilacinum strain 251 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 5, 10.1.2022, p. 9).










13zzzzzzzzzzzzk.



32022 R 0043: Commission Implementing Regulation (EU) 2022/43 of 13 January 2022 renewing the approval of the active substance flumioxazin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annexes to Commission Implementing Regulation (EU) No 540/2011 and to Implementing Regulation (EU) 2015/408 (OJ L 9, 14.1.2022, p. 7).










13zzzzzzzzzzzzl.



32022 R 0159: Commission Implementing Regulation (EU) 2022/159 of 4 February 2022 approving the low-risk active substance Bacillus amyloliquefaciens strain IT-45 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 26, 7.2.2022, p. 7).’










Article 2
The texts of Implementing Regulations (EU) 2021/2049, (EU) 2021/2068, (EU) 2021/2081, (EU) 2022/4, (EU) 2022/19, (EU) 2022/43 and (EU) 2022/159 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 10 December 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 9 December 2022.


For the EEA Joint Committee


The President

Kristján Andri STEFÁNSSON
            





(1)  
            OJ L 420, 25.11.2021, p. 6.

(2)  
            OJ L 421, 26.11.2021, p. 25.

(3)  
            OJ L 426, 29.11.2021, p. 28.

(4)  
            OJ L 1, 5.1.2022, p. 5.

(5)  
            OJ L 5, 10.1.2022, p. 9.

(6)  
            OJ L 9, 14.1.2022, p. 7.

(7)  
            OJ L 26, 7.2.2022, p. 7.

(*1)  No constitutional requirements indicated.